The DOI matches its Crossref record; 35 of the 35 references it cites were found in a registry or an index.
Development of a novel systemic gene delivery system for cancer therapy with a tumor-specific cleavable PEG-lipid
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Matsumura, Y., & Maeda, H. (1986) · PubMed · Cited by 6,781
Recent advances with liposomes as pharmaceutical carriers
Torchilin, V. P. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1632 · Cited by 5,282
Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations
Coussens, L. M., Fingleton, B., & Matrisian, L. M. (2002) · Science · doi:10.1126/science.1067100 · Cited by 2,761
Ogris, M., Brunner, S., Schüller, S., Kircheis, R., & Wagner, E. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300900 · Cited by 1,178
Regulation of matrix biology by matrix metalloproteinases
Mott, J. D., & Werb, Z. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.07.010 · Cited by 1,104
Schiffelers, R. M. (2004) · Nucleic Acids Research · doi:10.1093/nar/gnh140 · Cited by 901
Mishra, S., Webster, P., & Davis, M. E. (2004) · European Journal of Cell Biology · doi:10.1078/0171-9335-00363 · Cited by 730
Pharmacokinetics of stealth versus conventional liposomes: effect of dose
Allen, T. M., & Hansen, C. (1991) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(91)90201-i · Cited by 579
Doxorubicin loaded pH-sensitive polymeric micelles for reversal of resistant MCF-7 tumor
Lee, E. S., Na, K., & Bae, Y. H. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.12.018 · Cited by 577
Determination of protease cleavage site motifs using mixture-based oriented peptide libraries
Turk, B. E., Huang, L. L., Piro, E. T., & Cantley, L. C. (2001) · Nature Biotechnology · doi:10.1038/90273 · Cited by 560
Protamine sulfate enhances lipid-mediated gene transfer
Sorgi, F., Bhattacharya, S., & Huang, L. (1997) · Gene Therapy · doi:10.1038/sj.gt.3300484 · Cited by 451
Khalil, I. A., Kogure, K., Futaki, S., & Harashima, H. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m503202200 · Cited by 390
Self-citationWalker, G. F., Fella, C., Pelisek, J., Fahrmeir, J., Boeckle, S., Ogris, M., & Wagner, E. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2004.11.006 · Cited by 321
Ogris, M. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00230-x · Cited by 286
Oupicky, D., Ogris, M., Howard, K. A., Dash, P. R., Ulbrich, K., & Seymour, L. W. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0568 · Cited by 284
Miyamori, H., Takino, T., Kobayashi, Y., Tokai, H., Itoh, Y., Seiki, M., & Sato, H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m103083200 · Cited by 228
Sato, H., Kida, Y., Mai, M., Endo, Y., Sasaki, T., Tanaka, J., & Seiki, M. (1992) · PubMed · Cited by 225
Kogure, K., Moriguchi, R., Sasaki, K., Ueno, M., Futaki, S., & Harashima, H. (2004) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.04.024 · Cited by 218
Self-citationShin, J. (2003) · Journal of Controlled Release · doi:10.1016/s0168-3659(03)00232-3 · Cited by 208
Kirpotin, D., Hong, K., Mullah, N., Papahadjopoulos, D., & Zalipsky, S. (1996) · FEBS Letters · doi:10.1016/0014-5793(96)00521-2 · Cited by 206
Ambegia, E., Ansell, S., Cullis, P., Heyes, J., Palmer, L., & MacLachlan, I. (2005) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2005.02.001 · Cited by 202
Polyacetal−Doxorubicin Conjugates Designed for pH-Dependent Degradation
Tomlinson, R. D., Heller, J., Brocchini, S., & Duncan, R. (2003) · Bioconjugate Chemistry · doi:10.1021/bc030028a · Cited by 154
Hatakeyama, H., Akita, H., Maruyama, K., Suhara, T., & Harashima, H. (2004) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2004.05.025 · Cited by 147
Self-citationTumor targeting with surface-shielded ligand–polycation DNA complexes
Kircheis, R., Blessing, T., Brunner, S., Wightman, L., & Wagner, E. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00272-3 · Cited by 147
Tsuji, A., Yoshikawa, T., NISHIDE, K., Minami, H., Kimura, M., Nakashima, E., Terasaki, T., Miyamoto, E., Nightingale, C. H., & Yamana, T. (1983) · Journal of Pharmaceutical Sciences · doi:10.1002/jps.2600721103 · Cited by 145
Pharmacokinetic and pharmacodynamic considerations in gene therapy
Kamiya, H., Akita, H., & Harashima, H. (2003) · Drug Discovery Today · doi:10.1016/s1359-6446(03)02889-7 · Cited by 121
Self-citationZhang, Y. P., Sekirov, L., Saravolac, E. G., Wheeler, J. J., Tardi, P. G., Clow, K. A., Leng, E. C., Sun, R. R., Cullis, P. R., & Scherrer, P. (1999) · Gene Therapy · doi:10.1038/sj.gt.3300965 · Cited by 108
Low-pH-Sensitive PEG-Stabilized Plasmid−Lipid Nanoparticles: Preparation and Characterization
Choi, J. S., MacKay, J. A., & Szoka, F. C. (2003) · Bioconjugate Chemistry · doi:10.1021/bc025625w · Cited by 107
Zhang, J. X., Zalipsky, S., Mullah, N. N., Pechar, M., & Allen, T. M. (2003) · Pharmacological Research · doi:10.1016/j.phrs.2003.09.003 · Cited by 103
Biological stability of [3H]cholesteryl oleyl ether in cultured fibroblasts and intact rat
Stein, Y., Halperin, G., & Stein, O. (1980) · FEBS Letters · doi:10.1016/0014-5793(80)80771-x · Cited by 92
Holland, J. W., Cullis, P. R., & Madden, T. D. (1996) · Biochemistry · doi:10.1021/bi951999j · Cited by 90
Masuda, T., Akita, H., & Harashima, H. (2005) · FEBS Letters · doi:10.1016/j.febslet.2005.02.071 · Cited by 82
Self-citationA multifunctional envelope-type nano device for novel gene delivery of siRNA plasmids
Moriguchi, R., Kogure, K., Akita, H., Futaki, S., Miyagishi, M., Taira, K., & Harashima, H. (2005) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2005.05.021 · Cited by 72
Self-citationTandia, B.-M., Vandenbranden, M., Wattiez, R., Lakhdar, Z., Ruysschaert, J., & Elouahabi, A. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00150-3 · Cited by 53
Martin, G., & Jain, R. K. (1993) · Microvascular Research · doi:10.1006/mvre.1993.1048 · Cited by 37
Cited by
Fang, J., Nakamura, H., & Maeda, H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.04.009 · Cited by 3,559
Nanotechnology for Multimodal Synergistic Cancer Therapy
Fan, W., Yung, B., Huang, P., & Chen, X. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00258 · Cited by 1,791
Multistage nanoparticle delivery system for deep penetration into tumor tissue
Wong, C., Stylianopoulos, T., Cui, J., Martin, J., Chauhan, V. P., Jiang, W., Popović, Z., Jain, R. K., Bawendi, M. G., & Fukumura, D. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1018382108 · Cited by 1,062
Hatakeyama, H., Akita, H., & Harashima, H. (2011) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.09.001 · Cited by 645
Self-citationPoly(ethylene glycol)-modified Nanocarriers for Tumor-targeted and Intracellular Delivery
van Vlerken, L. E., Vyas, T. K., & Amiji, M. M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9284-6 · Cited by 645
Metadata
- Authors
- Hatakeyama, H., Akita, H., Kogure, K., Oishi, M., Nagasaki, Y., Kihira, Y., Ueno, M., Kobayashi, H., Kikuchi, H., & Harashima, H.
- Venue
- Gene Therapy
- Published
- 2006-08-17
- Volume
- 14
- Issue
- 1
- Pages
- 68-77
- ISSN
- 0969-7128 (ISSN-L)
- 1476-5462
- OpenAlex
- W2033023421
- Cited by
- 398
- References
- 35
- FWCI
- 6.88
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.